Structurally altered EVI-1 protein generated in the 3Q21Q26 syndrome.

被引：0
|
作者：
Ogawa, S
Kurokawa, M
Tanaka, T
Mitani, K
Inazawa, J
Hangaishi, A
Tanaka, K
Matsuo, Y
Minowada, J
Tsubota, T
Yazaki, Y
Hirai, H
机构：
[1] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN
[2] KYOTO PREFECTURAL UNIV MED,DEPT HYG,KYOTO 602,JAPAN
[3] HAYASHIBARA BIOCHEM LABS INC,FUJISAKI CELL CTR,OKAYAMA,JAPAN
[4] OKAYAMA CITY HOSP,DEPT INTERNAL MED,OKAYAMA,JAPAN
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2190 / 2190
页数：1
相关论文
共 50 条
  • [1] Structurally altered Evi-1 protein generated in the 3q21q26 syndrome
    Ogawa, S
    Kurokawa, M
    Tanaka, T
    Mitani, K
    Inazawa, J
    Hangaishi, A
    Tanaka, K
    Matsuo, Y
    Minowada, J
    Tsubota, T
    Yazaki, Y
    Hirai, H
    ONCOGENE, 1996, 13 (01) : 183 - 191
  • [2] DNA REARRANGEMENTS PROXIMAL TO THE EVI1 LOCUS ASSOCIATED WITH THE 3Q21Q26 SYNDROME
    LEVY, ER
    PARGANAS, E
    MORISHITA, K
    FICHELSON, S
    JAMES, L
    OSCIER, D
    GISSELBRECHT, S
    IHLE, JN
    BUCKLE, VJ
    BLOOD, 1994, 83 (05) : 1348 - 1354
  • [3] Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts
    Martinelli, G
    Ottaviani, E
    Buonamici, S
    Isidori, A
    Borsaru, G
    Visani, G
    Piccaluga, PP
    Malagola, M
    Testoni, N
    Rondoni, M
    Nucifora, G
    Tura, S
    Baccarani, M
    HAEMATOLOGICA, 2003, 88 (11) : 1221 - 1228
  • [4] Expression of EVI1 is not specific for AML with 3q21q26 aberrations.
    Schnittger, S
    Schoch, C
    Mellert, G
    Haferlach, T
    Hiddemann, W
    BLOOD, 1999, 94 (10) : 497A - 497A
  • [5] Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role?
    Breccia, M
    Petti, MC
    Ottaviani, E
    Mancini, M
    D'Elia, GM
    Mecarocci, S
    Alimena, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (02) : 438 - 441
  • [6] 3q21q26症候群
    胡济民
    北京军区医药, 1995, (05) : 397 - 397
  • [7] 3q21q26综合征
    栾英非
    日本医学介绍, 1995, (04) : 180 - 180
  • [8] GATA2 may contribute with EVI1 to the leukemogenic mechanism in patients with 3q21q26 rearrangements
    Vazquez, I
    Lahortiga, I
    Marcotegui, N
    Larrayoz, MJ
    Vicente, C
    Hernandez, JM
    Cervera, J
    Vidal, MJ
    Marquez, JA
    Calasanz, MJ
    Odero, MD
    BLOOD, 2005, 106 (11) : 799A - 800A
  • [9] Different ribophorin1/EVI1 fusion transcript are associated with 3q21q26 syndrome in acute myeloblastic leukemia patients.
    Martinelli, G
    Ottaviani, E
    Borsaru, G
    Testoni, N
    Terragna, C
    Montefusco, V
    Amabile, M
    Visani, G
    Pastano, R
    Nucifora, G
    Tura, S
    BLOOD, 1999, 94 (10) : 285B - 285B
  • [10] Molecular heterogeneity in the 3q21q26 syndrome. GATA-2 overexpression might be involved in the leukemic transformation.
    Lahortiga, I
    Vazquez, I
    Agirre, X
    Larrayoz, MJ
    Vizmanos, JL
    Calasanz, MJ
    Odero, MD
    BLOOD, 2003, 102 (11) : 849A - 849A
12345